| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.07 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.31 | 0.07 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.07 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |